Winston Kung
Director of Finance/CFO at ARRIVENT BIOPHARMA, INC.
Net worth: 18 126 $ as of 30/04/2024
Winston Kung active positions
Companies | Position | Start | End |
---|---|---|---|
JANUX THERAPEUTICS, INC. | Director/Board Member | 22/09/2022 | - |
Independent Dir/Board Member | 22/09/2022 | - | |
ARRIVENT BIOPHARMA, INC. | Director of Finance/CFO | 01/01/2024 | - |
Treasurer | 01/01/2024 | - |
Career history of Winston Kung
Former positions of Winston Kung
Companies | Position | Start | End |
---|---|---|---|
PMV PHARMACEUTICALS, INC. | Chief Operating Officer | 01/12/2017 | 04/01/2024 |
Director of Finance/CFO | 01/12/2017 | 04/01/2024 | |
Investor Relations Contact | 01/12/2017 | 04/01/2024 | |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Director/Board Member | 15/02/2016 | 24/11/2017 |
CELGENE | Corporate Officer/Principal | 01/04/2013 | 01/11/2017 |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Corporate Officer/Principal | 01/04/2013 | 01/02/2015 |
CITIGROUP INC. | Corporate Officer/Principal | 01/06/2010 | 01/04/2013 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Corporate Officer/Principal | 01/05/2007 | 01/06/2010 |
AMGEN INC. | Corporate Officer/Principal | 01/08/2004 | 01/05/2007 |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Winston Kung
Harvard Business School | Masters Business Admin |
Brown University | Undergraduate Degree |
Statistics
International
United States | 13 |
Operational
Corporate Officer/Principal | 5 |
Director/Board Member | 3 |
Director of Finance/CFO | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
CITIGROUP INC. | Finance |
PMV PHARMACEUTICALS, INC. | Commercial Services |
AMGEN INC. | Health Technology |
JANUX THERAPEUTICS, INC. | Health Technology |
ARRIVENT BIOPHARMA, INC. | Health Technology |
Private companies | 5 |
---|---|
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Commercial Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
- Stock Market
- Insiders
- Winston Kung
- Experience